Quote: Proposed changes to the Medicare drug benefit
The three classes of drugs — widely used antidepressants, antipsychotics and drugs that suppress the immune system to prevent the rejection of a transplanted organ — have enjoyed special “protected” status since the launch of the Medicare prescription benefit in 2006. That has meant that the private
Effects of Physician-Directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence by Anusua Datta and Dhaval M. Dave (National Bureau of Economic Research) Spending on prescription drugs (Rx) represents one of the fastest growing components of U.S. healthcare spending, and has
Pharmaceutical innovation and longevity
I’ve been reading an interesting working paper by Frank Lichtenberg, entitled “Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000-2009“: We examine the impact of pharmaceutical innovation, as measured by the vintage of prescription drugs used, on longevit
Kaiser: Webcast Noon 12/7 EST CMS estimates of state-by-state health spending CBO: Spending patterns for prescription drugs under Medicare part D Today in TIE: Reflex, Austin parses moral hazard, Dr. Rorschach brings a chart and Don says Medicare is simple while Austin says it is complicated, Don no
Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program, by Jason Abaluck and Jonathan Gruber (AER) We evaluate the choices of elders across their insurance options under the Medicare Part D Prescription Drug plan, using a unique dataset of prescription dru
You’d think we were all popping pills like crazy
But you’d be wrong: More than a quarter of Americans who take prescription drugs have skipped doses, split pills or cut other corners to save money in the last year, according to a new study by Consumer Reports… This telephone survey, of 1,154 adults who currently take at least one prescription drug
